Results 181 to 190 of about 28,321 (229)
Some of the next articles are maybe not open access.
The Hypercoagulability of Polycythemia Vera
Hospital Practice, 1993Thrombosis is the most common cause of death in patients with this myeloproliferative syndrome. Phlebotomy, hydroxyurea, and antiplatelet agents are the mainstays of therapy but may not stave off a lethal embolism.
W, Fields, N J, Freeman
openaire +2 more sources
Clinical Journal of Oncology Nursing, 2003
Polycythemia vera (PV) is a clonal stem cell disorder characterized by increased erythrocyte production. Its etiology is not fully understood, and hemorrhage, thrombosis, and hyperviscosity may occur at any time during the course of this disorder. Treatment depends on the most affected cell type, duration and severity of the condition, and patient age.
openaire +2 more sources
Polycythemia vera (PV) is a clonal stem cell disorder characterized by increased erythrocyte production. Its etiology is not fully understood, and hemorrhage, thrombosis, and hyperviscosity may occur at any time during the course of this disorder. Treatment depends on the most affected cell type, duration and severity of the condition, and patient age.
openaire +2 more sources
Anesthesia for polycythemia vera
Journal of Clinical Anesthesia, 1990Cystoscopy was postponed on an 80-year-old male found to have a hematocrit of 57%. After the diagnosis of polycythemia vera was made, he was phlebotomized and treated with hydroxyurea. He was readmitted 2 months later for transurethral resection of the prostate. After the induction of general endotracheal anesthesia with thiopental and succinylcholine,
openaire +2 more sources
Journal of the American Veterinary Medical Association, 1974
SUMMARY The historical and laboratory findings in 5 published reports and 3 additional cases of polycythemia vera in the dog were reviewed. The consistent abnormal findings included increased packed cell volume (pcv), hemoglobin concentration, red blood cell (rbc) count, rbc mass, and total blood volume.
openaire +2 more sources
SUMMARY The historical and laboratory findings in 5 published reports and 3 additional cases of polycythemia vera in the dog were reviewed. The consistent abnormal findings included increased packed cell volume (pcv), hemoglobin concentration, red blood cell (rbc) count, rbc mass, and total blood volume.
openaire +2 more sources
POLYCYTHEMIA VERA IN CHILDHOOD
Archives of Pediatrics & Adolescent Medicine, 1972To the Editor.—The recent communication by Natelson et al1at the first glance appears to add another report to the compendium of chromosomal abnormalities, specific or nonspecific, as the case may be. The nonspecific chromosomal abnormalities probably are not significant since they may not have any relation to the clinical nature or etiology of the ...
openaire +2 more sources
Treatment of Polycythemia Vera
Seminars in Thrombosis and Hemostasis, 2006The selection of treatment for patients with polycythemia vera (PV) still is the subject of much discussion among hematologists. It is emphasized that important physiologic and pathogenic components of the illness relate not only to the erythroid cell, but also to the megakaryocyte.
openaire +2 more sources
Polycythemia vera and other primary polycythemias
Current Opinion in Hematology, 2005Diagnosis and therapy of polycythemia vera are controversial since the molecular basis of polycythemia vera remains unknown. Distinguishing between polycythemia vera and other polycythemic disorders can be very challenging. The purpose of this review is to discuss the recent progress in this area and critically review the published data in context of ...
openaire +2 more sources
Journal of the American Medical Association, 1944
This is a final report on a case of polycythemia vera which was under observation for seventeen years, and for eleven of these years under continual treatment with phenylhydrazine hydrochloride. It is presented (1) because of the long period of treatment with the drug, (2) to record the changed blood picture during the last six years of life and (3) to
openaire +1 more source
This is a final report on a case of polycythemia vera which was under observation for seventeen years, and for eleven of these years under continual treatment with phenylhydrazine hydrochloride. It is presented (1) because of the long period of treatment with the drug, (2) to record the changed blood picture during the last six years of life and (3) to
openaire +1 more source

